Your browser doesn't support javascript.
loading
Targeting Glioblastoma Cells Expressing CD44 with Liposomes Encapsulating Doxorubicin and Displaying Chlorotoxin-IgG Fc Fusion Protein.
Mahmud, Hafizah; Kasai, Tomonari; Khayrani, Apriliana Cahya; Asakura, Mami; Oo, Aung Ko Ko; Du, Juan; Vaidyanath, Arun; El-Ghlban, Samah; Mizutani, Akifumi; Seno, Akimasa; Murakami, Hiroshi; Masuda, Junko; Seno, Masaharu.
Afiliação
  • Mahmud H; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. hfzhmhmd@gmail.com.
  • Kasai T; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. t-kasai@okayama-u.ac.jp.
  • Khayrani AC; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. apriliana41@gmail.com.
  • Asakura M; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. asakura@okayama-u.ac.jp.
  • Oo AKK; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. kokooo.aung@gmail.com.
  • Du J; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. djmail@yeah.net.
  • Vaidyanath A; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. arunvnath@okayama-u.ac.jp.
  • El-Ghlban S; Department of Chemistry, Biochemistry Division, Faculty of Science, El Menoufia University, Shebin El Kom, Menoufia 32511, Egypt. S_elghlban@yahoo.com.
  • Mizutani A; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. mizut-a@cc.okayama-u.ac.jp.
  • Seno A; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. aseno@okayama-u.ac.jp.
  • Murakami H; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. muraka-h@cc.okayama-u.ac.jp.
  • Masuda J; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. junkomasuda@okayama-u.ac.jp.
  • Seno M; Department of Medical Bioengineering, Graduate School of Natural Science and Technology, Okayama University, Okayama 700-0080, Japan. mseno@okayama-u.ac.jp.
Int J Mol Sci ; 19(3)2018 Feb 26.
Article em En | MEDLINE | ID: mdl-29495404
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Venenos de Escorpião / Proteínas Recombinantes de Fusão / Doxorrubicina / Glioblastoma / Receptores de Hialuronatos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Venenos de Escorpião / Proteínas Recombinantes de Fusão / Doxorrubicina / Glioblastoma / Receptores de Hialuronatos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça